Sinus Dilation Devices Market Seen Reaching $4.84 Billion by 2030

The sinus dilation devices market is projected to grow from $3.15 billion in 2025 to $3.42 billion in 2026, with North America leading in 2025 and Asia-Pacific expected to expand fastest through 2030. The report points to chronic sinusitis, outpatient treatment demand and balloon-based procedures as key growth drivers.

Why it matters: - The sinus dilation devices market is expanding as more patients and providers shift toward less invasive sinus treatments. - Growth in chronic sinusitis cases is increasing demand for devices that can open blocked sinus passages and support better drainage. - The market is also benefiting from higher use of outpatient and office-based ENT care, which can reduce procedure time and recovery burden.

What happened: - The Business Research Company released a market report on the sinus dilation devices market on August 26, 2026. - The report estimates the market will rise from $3.15 billion in 2025 to $3.42 billion in 2026. - The report projects the market will reach $4.84 billion by 2030. - North America held the largest regional market share in 2025. - Asia-Pacific is projected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - A free sample of the report is available here. - The full report is available here.

The details: - Sinus dilation devices are medical instruments designed to widen blocked sinus passages. - The devices help improve airflow and drainage and are used to ease symptoms tied to sinus obstruction. - Chronic sinusitis, endoscopic sinus surgeries, ENT specialty clinics, better diagnostic imaging and broader awareness of minimally invasive options are among the growth drivers cited for the market. - The report says future growth will also be supported by outpatient sinus treatments, shorter procedure times, pediatric sinus care, advanced navigation technologies and greater investment in ENT medical devices. - The report highlights balloon-based dilation, office-based ENT treatments and drug-eluting sinus implants as major trends shaping the market. - The report's 2026 package includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables. - The report includes contact details for expert inquiries, including Saumya Sahay and Oliver Guirdham, plus phone numbers and email addresses. - The company also provided social media links on LinkedIn, Facebook and X.

Between the lines: - The strongest demand signal is not just disease prevalence, but the move toward treatments that can be delivered faster and with less disruption to patients. - The regional split suggests the market is already mature in North America, while Asia-Pacific may be benefiting from broader access, rising diagnosis and faster adoption of ENT technologies. - The emphasis on drug-eluting implants and navigation tools suggests the market is moving from basic mechanical dilation toward more specialized procedural systems.

What's next: - The market is expected to keep growing through 2030 as outpatient and minimally invasive care expands. - Adoption of balloon sinuplasty, office-based procedures and pediatric applications is likely to shape product demand. - Investment in ENT devices and advanced navigation systems may continue to influence competitive positioning across regions.

The bottom line: - Sinus dilation devices are moving from a niche procedural category to a broader growth market, driven by chronic sinusitis and the push for faster, less invasive care.